Iran has a robust pharmaceutical and medical care industry which serves over 82 million people in the country.
A very specialized branch of medicine and technology production belongs to nuclear medicine. Iran has a fairly advanced structure for the production of nuclear medicine.
Due to its sensitivity and potential hazards, nuclear pharmaceuticals and associated machinery are heavily regulated. Nuclear medicine uses radioactive isotopes to detect and treat diseases.
From advances in cancer diagnosis and treatment, to recent breakthroughs in Alzheimers and dementia research, nuclear medicine is improving lives.
Nuclear medicine is just one part of a rapidly growing national pharmaceutical industry. In 2019, Irans pharmaceutical industry was valued at roughly three billion dollars.
Currently, 97 percent of domestic needs for medicine are manufactured in the country. Some drugs still need to be imported for particular ailments.
About 67 percent of raw materials for the pharmaceutical industry in Iran is provided by local companies.
Also it is worth mentioning that bio-pharma products made by the domestic knowledge-based companies and start-ups are worth billions.